Skip to content
S5583Senate2015-2016 Session

Directs physicians to screen newborns for neonatal abstinence syndrome

Sponsor Catharine YoungSD-57Affects Health
Status
In Senate Committee
Health
Impact
Pending
Passage
Pending

Bill progress

Step 2 of 7

In committee · Health

What's happening

Writing a plain-English summary… Track this bill to get it by email.

Why it matters

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Who cares

Headline styles

Sponsors

Primary sponsor
Catharine Young

Senator · Senate District 57

Chair, Housing, Construction And Community Development

No co-sponsors yet.

History

  1. Referred to health
  2. Referred to health

Full text

The text isn't available here yet. Check nysenate.gov.

Sponsor's memo

BILL NUMBER:S5583

Title of bill

An act to amend the public health law, in relation to requiring facili- ties to screen newborns for neonatal abstinence syndrome through toxico- logical screening of infants' meconium or urine

Purpose

This bill would require healthcare facilities to screen newborns for neonatal abstinence syndrome, which results from a fetus being exposed to opiates or narcotics while in the womb, through toxicological screen- ing.

Justification

Neonatal Abstinence Syndrome (NAS) is a group of symptoms that occur in a newborn who was exposed to prescription or addictive illegal drugs while in the mother's womb during pregnancy. Newborns have an alarmingly high rate of testing positive for NAS as a result of high rates of addiction to narcotics and other drugs in many regions of New York State. It is in the public interest to address this public health crisis.

The number of newborns that are diagnosed with NAS has increased each year between 2010 and 2012, a rate of 83.8 per 10,000 births. In Western New York, the birthrate for babies born with a drug-related diagnosis is more than twice the statewide average. Per 10,000 babies born, there are 179 diagnosed with drug related symptoms in Western New York, the high- est rate in the state.

This bill would help lessen negative health outcomes for newborns by requiring a standardized statewide method for healthcare facilities to test for NAS in newborns. In some instances, newborns may not exhibit signs or symptoms until a week or two after birth. Requiring that newborns be tested would allow health care professionals to respond quickly and appropriately to positive test results.

Legislative history

New Bill.

Fiscal implications

To be determined.

Effective date

This act shall take effect on the one hundred eightieth day after it shall have become a law; provided, however, that effective immediately, the addition, amendment and/or repeal of any rule or regulation neces-

sary for the implementation of this act on its effective date are authorized and directed to be made and completed on or before such effective date.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.